Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Safety of MAP0010 vs Pulmicort in Adult Asthmatics
NCT00554970Phase 2Completed
- Sponsor
- Allergan
- Start
- Nov 2007
- Primary completion
- Jan 2008
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of budesonide in asthma (4 arms), sponsored by Allergan. Primary endpoints: Cmax of Budesonide at Day 8, AUC(0-inf) of Budesonide at Day 8 and 1 more. Started Nov 2007; status: completed.
02
Drugs
budesonide
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00554970.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00554970.